| Autor: |
Yuriko Sueda, Hirokazu Tokuyasu, Momoka Atsuta, Hiromitsu Sakai, Katsunori Arai, Chika Esumi, Misato Mochizuki, Tomoki Itohara, Naoki Fujisawa, Akira Yamasaki |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Respiratory Medicine Case Reports, Vol 52, Iss , Pp 102131- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2213-0071 |
| DOI: |
10.1016/j.rmcr.2024.102131 |
| Popis: |
A 68-year-old woman with follicular lymphoma was treated with chemotherapy, including the anti-CD20 monoclonal antibody obinutuzumab, and achieved remission. A month after the administration of obinutuzumab, the patient contracted coronavirus disease 2019 (COVID-19), and various antiviral drugs were administered. However, the infection had not been eliminated. One year and three months after chemotherapy, peripheral B cell recovery was achieved, and the infection had resolved. This report provides insight into the course of COVID-19 in patients with impaired humoral immunity. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
